Please login to the form below

Not currently logged in
Email:
Password:

Former AstraZeneca VP joins Walgreens

Mark Lelinski leaves pharma for pharmacy

Mark Lelinksi WalgreensThe US' leading pharmacy group Walgreens has tapped the pharma industry to lead its efforts in market access.

Mark Lelinski (pictured) will leave his role as VP, Americas region marketing and sales, at pharma company AstraZeneca (AZ) to join the drug retailer, which holds a 45 per cent stake in fellow pharmacy group Alliance Boots.

As Walgreens' corporate VP, market access, he will be responsible for the company's contracting and pricing strategies, as well as integration efforts across the pharmacy, health and wellness division and managing market strategies.

Lelinksi spent a total of nine years at AZ in several marketing and strategy roles, during which time he was responsible for implementing new commercial capabilities across the US and Canada and building new capabilities in Latin America to improve market access.

Prior to joining AstraZeneca, Lelinski was a partner at Accenture, where he headed the pharmaceutical marketing and sales effectiveness practice.

“His experience in managed market roles both in the US and internationally is the right fit for where Walgreens is headed,” said Kermit Crawford, Walgreens president of pharmacy, health and wellness.

“As a strategic partner of choice in the healthcare industry, we believe Mark's relationship-driven approach will help us strengthen our partnerships and create more value from the emerging models and markets that will be key to our growth moving forward.”

18th July 2013

From: Sales, Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hanson Zandi

Hanson Zandi is a Creative and Digital Healthcare Agency. We combine 30 years’ experience with the enthusiasm of a start-up...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics